Inceptionr LLC lessened its stake in shares of Kimberly-Clark Co. (NYSE:KMB - Free Report) by 49.0% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,632 shares of the company's stock after selling 2,528 shares during the period. Inceptionr LLC's holdings in Kimberly-Clark were worth $345,000 as of its most recent SEC filing.
Other hedge funds have also added to or reduced their stakes in the company. Thompson Siegel & Walmsley LLC raised its holdings in shares of Kimberly-Clark by 1.5% in the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 5,337 shares of the company's stock worth $759,000 after purchasing an additional 77 shares during the period. Truvestments Capital LLC raised its stake in shares of Kimberly-Clark by 2.7% in the third quarter. Truvestments Capital LLC now owns 2,981 shares of the company's stock valued at $424,000 after buying an additional 78 shares during the period. Confluence Wealth Services Inc. lifted its position in shares of Kimberly-Clark by 5.1% during the 4th quarter. Confluence Wealth Services Inc. now owns 1,637 shares of the company's stock valued at $208,000 after buying an additional 80 shares during the last quarter. YHB Investment Advisors Inc. grew its stake in shares of Kimberly-Clark by 3.4% during the 4th quarter. YHB Investment Advisors Inc. now owns 2,519 shares of the company's stock worth $330,000 after acquiring an additional 83 shares during the period. Finally, Ascent Wealth Partners LLC lifted its holdings in Kimberly-Clark by 1.0% during the fourth quarter. Ascent Wealth Partners LLC now owns 9,321 shares of the company's stock valued at $1,221,000 after purchasing an additional 90 shares during the last quarter. Institutional investors own 76.29% of the company's stock.
Insider Transactions at Kimberly-Clark
In related news, VP Andrew Drexler sold 2,500 shares of the firm's stock in a transaction on Friday, February 21st. The stock was sold at an average price of $140.00, for a total value of $350,000.00. Following the completion of the sale, the vice president now owns 2,553 shares of the company's stock, valued at $357,420. This trade represents a 49.48 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.62% of the company's stock.
Kimberly-Clark Trading Down 1.6 %
KMB stock traded down $2.37 during trading on Wednesday, hitting $141.73. 479,770 shares of the company traded hands, compared to its average volume of 2,039,410. The firm has a market capitalization of $47.01 billion, a PE ratio of 18.76, a P/E/G ratio of 4.46 and a beta of 0.36. Kimberly-Clark Co. has a 1 year low of $123.02 and a 1 year high of $150.45. The company has a debt-to-equity ratio of 7.05, a quick ratio of 0.54 and a current ratio of 0.80. The company has a 50-day moving average of $132.96 and a 200-day moving average of $136.48.
Kimberly-Clark (NYSE:KMB - Get Free Report) last posted its quarterly earnings results on Tuesday, January 28th. The company reported $1.50 EPS for the quarter, meeting analysts' consensus estimates of $1.50. Kimberly-Clark had a net margin of 12.69% and a return on equity of 201.43%. Analysts predict that Kimberly-Clark Co. will post 7.5 earnings per share for the current fiscal year.
Kimberly-Clark Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 2nd. Shareholders of record on Friday, March 7th will be issued a $1.26 dividend. The ex-dividend date is Friday, March 7th. This represents a $5.04 annualized dividend and a yield of 3.56%. This is a boost from Kimberly-Clark's previous quarterly dividend of $1.22. Kimberly-Clark's dividend payout ratio (DPR) is 66.75%.
Wall Street Analysts Forecast Growth
Several research firms have recently issued reports on KMB. UBS Group boosted their price target on shares of Kimberly-Clark from $132.00 to $134.00 and gave the company a "neutral" rating in a research report on Wednesday, January 29th. TD Cowen cut shares of Kimberly-Clark from a "buy" rating to a "hold" rating and set a $145.00 target price on the stock. in a report on Wednesday, January 8th. Piper Sandler reaffirmed an "overweight" rating and issued a $158.00 price target (down from $161.00) on shares of Kimberly-Clark in a report on Wednesday, January 29th. Royal Bank of Canada reiterated an "outperform" rating and set a $165.00 price objective on shares of Kimberly-Clark in a research note on Friday, January 24th. Finally, Barclays cut their target price on Kimberly-Clark from $144.00 to $132.00 and set an "equal weight" rating for the company in a research note on Friday, January 17th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $143.64.
View Our Latest Stock Report on Kimberly-Clark
About Kimberly-Clark
(
Free Report)
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Read More

Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.